NASDAQ:ANIK
Anika Therapeutics Inc. Stock News
$25.90
+0.110 (+0.427%)
At Close: Apr 24, 2024
New Strong Sell Stocks for April 4th
11:57am, Monday, 04'th Apr 2022 Zacks Investment Research
AKU, ANIK, and AY have been added to the Zacks Rank #5 (Strong Sell) List on April 4, 2022.
New Strong Sell Stocks for April 4th
09:02am, Monday, 04'th Apr 2022
AKU, ANIK, and AY have been added to the Zacks Rank #5 (Strong Sell) List on April 4, 2022.
New Strong Sell Stocks for March 28th
02:48pm, Monday, 28'th Mar 2022 Zacks Investment Research
ALIM, ANIK, and APPF have been added to the Zacks Rank #5 (Strong Sell) List on March 28, 2022
New Strong Sell Stocks for March 28th
12:03pm, Monday, 28'th Mar 2022
ALIM, ANIK, and APPF have been added to the Zacks Rank #5 (Strong Sell) List on March 28, 2022
Anika to Showcase its Transformation into a Global Leader in Joint Preservation during the 2022 AAOS Annual Meeting
12:30pm, Wednesday, 23'rd Mar 2022 GlobeNewswire Inc.
Anika is an innovative joint preservation company focused on the early intervention orthopedic continuum of care including OA pain management, regenerative solutions, sports medicine, and bone preserv
New Strong Sell Stocks for March 21st
01:41pm, Monday, 21'st Mar 2022 Zacks Investment Research
ARAY, AKU, and ANIK have been added to the Zacks Rank #5 (Strong Sell) List on March 21, 2022
New Strong Sell Stocks for March 21st
11:17am, Monday, 21'st Mar 2022
ARAY, AKU, and ANIK have been added to the Zacks Rank #5 (Strong Sell) List on March 21, 2022
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11:00pm, Tuesday, 15'th Mar 2022 GlobeNewswire Inc.
BEDFORD, Mass., March 15, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that it granted:
Anika Therapeutics, Inc. 2021 Q4 - Results - Earnings Call Presentation
09:47pm, Friday, 11'th Mar 2022 Seeking Alpha
Anika Therapeutics: New Share Price Low May Imply New Upside Opportunity
07:17pm, Friday, 11'th Mar 2022 Seeking AlphaAnika Therapeutics: New Share Price Low May Imply New Upside Opportunity
02:17pm, Friday, 11'th Mar 2022
Anika Therapeutics' share price is being punished by the market owing to some possibly over-ambitious growth projections made in June last year.
Anika to Participate in the Canaccord Genuity Musculoskeletal Conference
09:05pm, Thursday, 10'th Mar 2022 GlobeNewswire Inc.
BEDFORD, Mass., March 10, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management wil
Anika Therapeutics stock falls 17% after Barrington, Stephens downgrade on outlook
04:37pm, Wednesday, 09'th Mar 2022 Seeking Alpha
Anika Therapeutics <> stock plummeted following its Q4 results and downgrades by Stephens and Barrington Research.Stephens analyst Chris Cooley downgraded Anika to Equal Weight…
Anika Therapeutics Inc''s (ANIK) CEO Cheryl Blanchard on Q4 2021 Results - Earnings Call Transcript
02:58am, Wednesday, 09'th Mar 2022 Seeking AlphaAnika Therapeutics Inc's (ANIK) CEO Cheryl Blanchard on Q4 2021 Results - Earnings Call Transcript
09:58pm, Tuesday, 08'th Mar 2022
Anika Therapeutics Inc's (ANIK) CEO Cheryl Blanchard on Q4 2021 Results - Earnings Call Transcript
